A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...
Aug 26 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback